Scott Nelson Live

Scott Nelson Live

By Scott NelsonBusinessEntrepreneurship
Download on the App Store

All Scott Nelson Live episodes

  • From Investor Pitch to Eventual Partnership: Interview With HealthQuest Capital Founder Garheng Kong

    In this episode, we caught up with the  HealthQuest Capital Founder,  Garheng Kong, who worked at GlaxoSmithKline, McKinsey, and TherOx before transitioning into healthcare investing with Intersouth Partners and Sofinnova. 

    Garheng’s resume is broad and deep. He has earned numerous degrees from two of the nation’s most prestigious universities — Stanford and Duke — and funded an equally impressive collection of healthcare companies throughout his career. 

    Garheng and his team see up to 1,000 investment opportunities in any given year. The experience has taught him how to assess which ones are right for the firm, and which he can afford to let go of. 

    In this interview, Garheng shares keen insights for startups and innovators preparing to pursue funding, along with observations about how the healthcare industry has shifted thanks to the global COVID-19 pandemic.

    56 min
  • How To Launch Your Medical Device With a Global Perspective: Interview With Lightpoint Medical CEO Graeme Smith

    In this episode, we’re talking with Lightpoint Medical CEO Graeme Smith, a medtech veteran with over 32 years of experience in the industry. 

    After joining Lightpoint earlier this year, Graeme was charged with commercializing its drop-in gamma probe, SENSEI, a revolutionary tool used in surgeries to non-invasively identify the presence of cancer. 

    In this Medsider interview, Graeme shares his tried and true strategies for successful commercial launches and how to introduce products using a global distribution model.

    53 min
  • Why Your Medical Device Company Needs Different Value Props For Different Stakeholders: Interview With Steve Anderson, Co-Founder and CEO of Preceptis Medical

    In this episode, we caught up with Steve Anderson, CEO of Preceptis Medical, and a serial medical device entrepreneur. 

    While serving as CEO of Acorn Cardiovascular, he and a neighbor came up with the idea of creating a device that could help doctors insert a tube in children’s ears in the doctor’s office instead of the operating room. They ended up starting Preceptis Medical in 2011, and in 2020, their Hummingbird device received clearance from the FDA.

    In this discussion, Steve explains why your value proposition needs to be front of mind from the start, why having someone who’s been there and done it before can help you navigate the process of getting to market and writing a study protocol that shows regulators exactly what they need to see.

    59 min
  • Why You Can’t Build a Medtech Start-Up Without Publicity: Interview with Peter Vranes, CEO of Nutromics

    In this episode, we caught up with chemical engineer and serial entrepreneur Peter Vranes, the Co-Founder and CEO of Nutromics, an Australian medtech company that is developing a digitally connected wearable patch to track molecular targets.

    Previously, Peter founded Biocore Technologies, which developed natural cosmeceutical skincare brands with distribution in 1,500 retailers throughout Australia. He had a successful exit in 2013.

    In this fun discussion, Peter explains how he learned to embrace publicity as a necessary part of doing business, why getting your device approved goes beyond government regulatory bodies and the reason he never stops raising money. 

    58 min
  • Doubling Down on Your Mission by Diversifying Your Medtech Portfolio: Interview With ReShape Lifesciences CEO Bart Bandy

    In this episode, we’re talking with ReShape Lifesciences CEO Bart Bandy, who started out selling medical equipment door-to-door, then landed a spot in the first sales class for Ethicon Endo-Surgery. He ran the company’s global sales and managed the San Francisco division, before becoming the Group Marketing Manager of Karl Storz Endoscopy.

    In 1999, Bart was recruited to become COO of laparoscopic weight loss startup Inamed. He helped manage the company’s $3.5 billion acquisition by Allergan in 2006. Then in 2019, he became CEO and President of ReShape, which had just acquired the Lap-Band, previously owned by Inamed.

    In this discussion, Bart explains how he writes and tests his presentations for maximum impact, the challenges and solutions of moving manufacturing from Costa Rica to the U.S., and why he wanted to add telemedicine to ReShape Lifesciences without moving away from the brand’s core mission.

    53 min
  • When You Should Give a Struggling Medtech Company a Second Chance: Interview With IONIQ CEO Jared Bauer

    In this episode, we caught up with IONIQ Sciences CEO Jared Bauer, who has spent his career turning around struggling medtech companies. He acquired BurnFree Products in 2012, selling it four years later. In 2014, he became CEO of the mobile diagnostics system ApolloDx. Shortly after, he became CEO of the spin-off company Cibus Biotechnologies, which makes a handheld diagnostic system to test for infectious diseases. 

    In this conversation, Jared explains the two key factors he looks at when determining whether a medical device company is worth trying to turn around, why finding investors who really care about your mission is a strategic benefit, and why he hopes that IONIQ’s devices will one day have a place in your medicine cabinet. 

    54 min
  • Why Your Medtech Strategy Should Start with Healthcare Payers: Interview with Health Economist Nic Anderson

    In this episode, we caught up with health economist, Nic Anderson, who spent seven years at Intermountain Healthcare on the payer side. He learned first-hand what evidence insurers need to convince them to cover a new medical device or healthcare technology. 

    After co-founding a biotech company, Nic turned his experience as a payer into an in-demand consultancy. He’s also served on payer advisory boards and was an expert in residence at a digital health accelerator in Dubai. He now works as a health economist for Boston Scientific.

    In this conversation, Nic explains why medtech companies, in particular, need to win over insurance payers, how investing early in a health economics and market access (HEMA) team will help you do that, and how to write a dossier a payer won’t want to throw out the window.

    57 min
  • How to Raise Capital for Your Medical Device Start-Up: Interview with Giovanni Lauricella and Aaron Green

    In this episode, we caught up with Giovanni Lauricella and Aaron Green to discuss all things related to fundraising for early-stage medical device start-ups. 

    In this interview, we learn about the ins and outs of raising medtech capital, what investors want to see in a medical device start-up, and best practices for pitching potential partners. But first, here’s a bit more about their backgrounds:

    Giovanni Lauricella holds a Bachelor’s in Finance, a Master’s in Regulatory Affairs in Medical Devices, Biologics, and Pharmaceuticals, a Harvard University Certificate for Advanced Negotiation Strategy, and a Università Bocconi Certificate for Private Equity and Venture Capital. He has more than a decade of experience partnering with startups, SMEs, boards of directors, and investors on structuring technical and commercial teams from the C-level to individual contributors. Giovanni and his team have hired more than 7,000 employees for over 500 startups in more than 40 countries and assisted in facilitating capital raises for startups that amount to more than $150 million.

    Aaron Green has a Ph.D. in computational chemistry from UCLA. In 2014, he became the first hire at Neural Analytics (now NovaSignal) where he held leadership roles spanning clinical, finance, sales, and marketing. Aaron currently runs U.S. operations for Labgnostic, a global interoperability platform for clinical laboratories. He co-founded MedTech Money with Giovanni Lauricella in 2020 and founded ExtractEx, a botanical extraction startup, in 2021.

    1 hr 28 min
  • How to Get a Medical Device Startup Off the Ground: Interview with Asha Parekh, CEO of FrontLine Medical Technologies

    In this episode, we’re talking with Dr. Asha Parekh, a biomedical engineer and the co-founder & CEO of FrontLine Medical Technologies, a Canadian medical device startup. FrontLine has developed a novel REBOA device that helps trauma patients survive in emergency situations. If you're not familiar, REBOA stands for Resuscitative Endovascular Balloon Occlusion of the Aorta.

    In this discussion with Asha, we learn about her medtech journey from early-stage device prototypes to raising venture capital to navigate the global regulatory landscape. But first, here’s a bit more on Asha’s background:

    Asha has a Ph.D. in biomedical engineering from Western University in Ontario. In 2015, she partnered with Dr. Adam Power, a practicing vascular surgeon, to co-found FrontLine, which makes the COBRA-OS device for trauma patients.

    56 min
  • How to Successfully Launch a New Medical Device: Interview with Mark Toland, CEO of Medical Micro Instruments

    In this episode, we're chatting with Mark Toland, a veteran medtech executive who is the CEO of MMI, a startup medical device company in the robotics space.

    MMI stands for Medical Micro Instruments, and it’s an Italian company that’s developing a surgical robotic system capable of performing microsurgery on capillaries, small vessels, and other parts of the body existing robotic technology can’t reach. We’re going to dig into the robotics arena and chat about things like growing medtech startups, raising venture capital, positioning for an acquisition, and keys to successful commercial launches. First, here’s a bit more on Mark's background: 

    Before MMI, Mark was the CEO of Corindus, transforming the company into a leader in vascular robotics before it was acquired by Siemens for $1.1 billion in 2019. Prior to Corindus, Mark was at Boston Scientific for over 15 years, serving as Senior Vice President, where he built the company’s global solutions business and led all aspects of the U.S. commercial team’s cardiovascular businesses, representing approximately $4 billion in revenue. 

    He also serves on the Board of Directors for Cardiologs, a cardiovascular AI company, and Amplitude Vascular Systems, an intravascular lithotripsy company. He also serves as a partner and EIR at Biostar Capital, a healthcare-focused venture capital firm. Mark got his bachelor’s in business from the University of Louisville.

    58 min